Immunotype and immunohistologic characteristics of tumor-infiltrating immune cells are associated with clinical outcome in metastatic melanoma G Erdag, JT Schaefer, ME Smolkin, DH Deacon, SM Shea, LT Dengel, ... Cancer research 72 (5), 1070-1080, 2012 | 597 | 2012 |
Immunologic and clinical outcomes of a randomized phase II trial of two multipeptide vaccines for melanoma in the adjuvant setting CL Slingluff, GR Petroni, KA Chianese-Bullock, ME Smolkin, S Hibbitts, ... Clinical Cancer Research 13 (21), 6386-6395, 2007 | 185 | 2007 |
Molecular targets for tumour progression in gastrointestinal stromal tumours N Koon, R Schneider-Stock, M Sarlomo-Rikala, J Lasota, M Smolkin, ... Gut 53 (2), 235-240, 2004 | 169 | 2004 |
Effect of granulocyte/macrophage colony-stimulating factor on circulating CD8+ and CD4+ T-cell responses to a multipeptide melanoma vaccine: outcome of a multicenter randomized … CL Slingluff, GR Petroni, WC Olson, ME Smolkin, MI Ross, NB Haas, ... Clinical Cancer Research 15 (22), 7036-7044, 2009 | 165 | 2009 |
Accuracy of assigned BI-RADS breast density category definitions BT Nicholson, AP LoRusso, M Smolkin, VE Bovbjerg, GR Petroni, ... Academic radiology 13 (9), 1143-1149, 2006 | 148 | 2006 |
Cluster stability scores for microarray data in cancer studies M Smolkin, D Ghosh BMC bioinformatics 4 (1), 36, 2003 | 145 | 2003 |
Randomized multicenter trial of the effects of melanoma-associated helper peptides and cyclophosphamide on the immunogenicity of a multipeptide melanoma vaccine CL Slingluff Jr, GR Petroni, KA Chianese-Bullock, ME Smolkin, MI Ross, ... Journal of clinical oncology 29 (21), 2924, 2011 | 132 | 2011 |
PD-L1, PD-L2 and PD-1 expression in metastatic melanoma: correlation with tumor-infiltrating immune cells and clinical outcome JM Obeid, G Erdag, ME Smolkin, DH Deacon, JW Patterson, L Chen, ... Oncoimmunology 5 (11), e1235107, 2016 | 129 | 2016 |
Helper T-cell responses and clinical activity of a melanoma vaccine with multiple peptides from MAGE and melanocytic differentiation antigens CL Slingluff Jr, GR Petroni, W Olson, A Czarkowski, WW Grosh, ... Journal of Clinical Oncology 26 (30), 4973, 2008 | 127 | 2008 |
Modular construction of a signaling scaffold: MORG1 interacts with components of the ERK cascade and links ERK signaling to specific agonists T Vomastek, HJ Schaeffer, A Tarcsafalvi, ME Smolkin, EA Bissonette, ... Proceedings of the National Academy of Sciences 101 (18), 6981-6986, 2004 | 125 | 2004 |
Prognostic value of albumin in patients with head and neck cancer D Danan, DC Shonka Jr, Y Selman, Z Chow, ME Smolkin, MJ Jameson The Laryngoscope 126 (7), 1567-1571, 2016 | 119 | 2016 |
A multipeptide vaccine is safe and elicits T-cell responses in participants with advanced stage ovarian cancer KA Chianese-Bullock, WP Irvin Jr, GR Petroni, C Murphy, M Smolkin, ... Journal of immunotherapy 31 (4), 420-430, 2008 | 114 | 2008 |
Loss of the urothelial differentiation marker FOXA1 is associated with high grade, late stage bladder cancer and increased tumor proliferation DJ DeGraff, PE Clark, JM Cates, H Yamashita, VL Robinson, X Yu, ... PloS one 7 (5), e36669, 2012 | 112 | 2012 |
Radical cystectomy with ileal conduit diversion: early prospective evaluation of the impact of robotic assistance JJ Rhee, S Lebeau, M Smolkin, D Theodorescu BJU international 98 (5), 1059-1063, 2006 | 109 | 2006 |
Shipping blood to a central laboratory in multicenter clinical trials: effect of ambient temperature on specimen temperature, and effects of temperature on mononuclear cell … WC Olson, ME Smolkin, EM Farris, RJ Fink, AR Czarkowski, JH Fink, ... Journal of translational medicine 9 (1), 26, 2011 | 99 | 2011 |
Amelanotic melanomas presenting as red skin lesions: a diagnostic challenge with potentially lethal consequences SE McClain, KB Mayo, AL Shada, ME Smolkin, JW Patterson, ... International journal of dermatology 51 (4), 420-426, 2012 | 95 | 2012 |
Profiling bladder cancer organ site-specific metastasis identifies LAMC2 as a novel biomarker of hematogenous dissemination SC Smith, B Nicholson, M Nitz, HF Frierson Jr, M Smolkin, G Hampton, ... The American journal of pathology 174 (2), 371-379, 2009 | 83 | 2009 |
Infrared thermography of cutaneous melanoma metastases AL Shada, LT Dengel, GR Petroni, ME Smolkin, S Acton, CL Slingluff Jr journal of surgical research 182 (1), e9-e14, 2013 | 77 | 2013 |
Histologic changes in the breast with menopausal hormone therapy use: correlation with breast density, estrogen receptor, progesterone receptor, and proliferation indices JA Harvey, RJ Santen, GR Petroni, VE Bovbjerg, ME Smolkin, FS Sheriff, ... Menopause (New York, NY) 15 (1), 67, 2008 | 74 | 2008 |
Immunity to melanoma antigens: from self‐tolerance to immunotherapy CL Slingluff Jr, KA Chianese‐Bullock, TNJ Bullock, WW Grosh, ... Advances in immunology 90, 243-295, 2006 | 74 | 2006 |